OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.630
-0.140 (-7.91%)
At close: Apr 28, 2026, 4:00 PM EDT
1.680
+0.050 (3.07%)
After-hours: Apr 28, 2026, 8:00 PM EDT
OS Therapies Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for OS Therapies stock have an average target of 18.5, with a low estimate of 17 and a high estimate of 20. The average target predicts an increase of 1,034.97% from the current stock price of 1.63.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OS Therapies stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,126.99% | Apr 8, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,126.99% | Mar 27, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,126.99% | Mar 9, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,126.99% | Feb 5, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,126.99% | Jan 5, 2026 |
Financial Forecast
Revenue This Year
4.85M
Revenue Next Year
13.66M
from 4.85M
Increased by 181.96%
EPS This Year
-0.43
from -0.98
EPS Next Year
-0.17
from -0.43
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 15.0M | 33.2M | ||||||
| Avg | 4.8M | 13.7M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 586.2% | ||||||
| Avg | - | 182.0% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.13 | -0.01 | ||||||
| Avg | -0.43 | -0.17 | ||||||
| Low | -0.77 | -0.27 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.